This article describes data related to the research article titled "Functional characterization of importin α8 as a classical nuclear localization signal receptor" [1] . A GST pull-down assay showed that both importin α1 and α8, which are classical nuclear localization signal (cNLS) receptors, can form a dimer with importin α6, α7, or α8. Importin α8 has higher dimer-forming ability than importin α1. In addition, our data show that either importin α1 or importin α8 can form a heterodimer with importin α3, which exists in a preformed complex with cNLS substrates such as the conventional SV40TNLS or the p53 protein, resulting in the release of the cNLS substrates from importin α3.
These data are valuable to researchers interested in the molecular mechanisms by which the importin α-cNLS substrate complex dissociates in the nucleus. These data show that importin α1 and α8 have substantial differences in dimer-forming ability, despite both proteins belonging to the same subfamily.
These data provide a new insight into the function of nuclear-localized importin αs.
Data
To examine whether importin αs can directly bind with other importin α subtypes, FLAG-tagged importin α6, α7, or α8 recombinant proteins were incubated with either GST-importin α8, or GSTimportin α1, and analyzed by western blotting (Fig. 1A) . To investigate the effect of heterodimerization of importin αs on its substrate binding, either an importin α3-SV40TNLS complex, or an importin α3-p53 complex was incubated with increasing amounts of FLAG-importin α8, or α1 recombinant proteins, and analyzed by western blotting (Figs. 1B and 2).
Experimental design, materials and methods

Plasmid construction
The N-terminus FLAG-tagged cDNAs encoding full-length human importin α6 (KPNA5, NM_012316) or full-length human-importin α7 (KPNA6, NM_002269) were amplified from either HEK293 cells or MRK-nu-1 cells (JCRB Cell Bank, Osaka, Japan) by PCR using the following primers: importin α6 Forward: 5 0 -CCCGAATTCCGCCATGGACTACAAGGACGACGACGACAAGATGGATGCCATGGCTAGTCC-3 0 and importin α6 Reverse: 5 0 -CCCGCGGCCGCCTCGAGTTAAAGTTGAAATCCATCC-3 0 or importin α7 Forward: 5 0 -CCCGAATTCCGCCATGGACTACAAGGACGACGACGACAAGATGGAGACCATGGCGAGC-3 0 and importin α7 Reverse: 5 0 -CCCGCGGCCGCCTCGAGTTATAGCTGGAAGCCCTCC-3 0 . The PCR program was as follows: 2 min at 94°C followed by 40 cycles of 30 s at 98°C and 15 min at 68°C. The PCR products were digested with EcoRI and NotI, and then subcloned into the pGEX6P3 plasmid (GE Healthcare, Tokyo, Japan). The construct integrity of pGEX6P3/FLAG-h-importin α6 and pGEX6P3/FLAG-h-importin α7 was confirmed by DNA sequencing using the following primers: pGEX 5 0 sequencing primer: 5 0 -GGGCTGGCAAGC-CACGTTTGGTG-3 0 , pGEX 3 0 sequencing primer: 5 0 -CCGGGAGCTGCATGTGTCAGAGG-3 0 , importin α6 sequencing primer: 5 0 -GCATCTGGAACTTTTCTGCATACC-3 0 , or importin α7 sequencing primer: 5 0 -GTA-
The human-importin α8 (KPNA7, NM_001145715) cDNA with the FLAG-tag at the N-terminus was amplified by PCR from the pcDNA5/3xFLAG-h-importin α8 plasmid [1] . The primers were as follows: importin α8 Forward: 5 0 -CCCGAATTCCGCCATGGACTACAAGGACGACGACGACAAGATGCCGACCTTA-GATGCTCC-3 0 and importin α8 Reverse: 5 0 -CCCGCGGCCGCCTCGAGCTATTTTTTTGCTAAGC-3 0 . The PCR program was the same as that described above. The PCR products were inserted into EcoRI and NotI sites of pGEX6P3, and then sequenced using either the pGEX 5 0 or pGEX 3 0 sequencing primer and the importin α8 sequencing primer: 5 0 -CAACATCGCTTCAGGGACTTCG-3 0 .
The construct encoding SV40 large T antigen NLS (PPKKKRKVED, pGEX6P2-SV40TNLS-GFP) was subcloned from pGEX2T-SV40TNLS-GFP [2] . The plasmids pGEX6P3/FLAG-human-importin α1 (KPNA2), pGEX6P2-mouse-importin α2 (KPNA2, which we referred to as m-importin α1), and pGEX2T-human-importin α3 (KPNA4, Qip1) were obtained as described previously [1, 3, 4] .
The human cDNA encoding the tumor protein p53 (NM_000546) was amplified from MCF7 cells by PCR performed using the following primers: p53 Forward: 5 0 -CACGGATCCATGGAGGAGCCG-CAGTCAGATC-3 0 and p53 Reverse: 5 0 -GGACTCGAGTCAGTCTGAGTCAGGCCCTTCTG-3 0 . The PCR program was as follows: one cycle of 2 min at 94°C; 40 cycles of 15 s at 94°C, 30 sec at 64°C, and 1 min 20 s at 68°C; and one cycle of 10 min at 68°C. The PCR product was subcloned into the BamHI and XhoI sites of pGEX6P1, and then verified by sequencing.
Recombinant protein purification
Recombinant proteins fused to GST were purified as follows: The expression vectors were transformed into Escherichia coli Rosetta, and then the cells were grown at 37°C in LB medium containing
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Antibodies
The following antibodies were used for western blotting: anti-FLAG M2 antibody (F1804, 0.1 μg/mL, Sigma-Aldrich, St. Louis, MO, USA), anti-GST antibody (sc-138, 0.04 μg/mL, Santa Cruz Biotechnology, Texas, USA), anti-GFP antibody (M048-3, 0.1 μg/mL, MBL, Nagoya, Japan), anti-p53 (FL-393) antibody (sc-6243, 0.04 μg/mL, Santa Cruz Biotechnology), and horseradish peroxidase (HRP)conjugated anti-mouse or anti-rabbit IgG secondary antibodies (1: 10,000 dilution, Jackson Immu-noResearch Lab., West Grove, PA, USA)
Western blotting
Samples were loaded on a 10% SDS-PAGE gel, and the separated proteins in the gel were transferred onto an Immobilon-P membrane (PVDF membrane; Merck Millipore, Darmstadt, Germany) using a semi-dry transfer blotting system (Trans-Blot Turbo Transfer System, BioRad Laboratories, Inc., Hercules, CA, USA). The membrane was blocked with blocking buffer consisting of 3% skim milk in Tris-buffered saline (TBS; TAKARA BIO, Shiga, Japan) with 0.05% Tween (TBS-T) for 1 h. The membrane was probed with primary antibodies diluted in Can Get Signal Immunoreaction Enhancer Solution 1 (TOYOBO, Osaka, Japan) at 4°C overnight, and then incubated with the HRP-conjugated secondary antibody diluted in Can Get Signal Immunoreaction Enhancer Solution 2 (TOYOBO) at room temperature (RT) for 1 h. After the membrane was washed with TBS-T, it was developed with Chemi-Lumi One L or Super (Nacalai Tesque). The intensity of each western blot signal was quantified by Image J software (http://rsbweb.nih.gov/ij/).
